Abeona Therapeutics Inc. (NASDAQ:ABEO) Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ET
Company Participants
Greg Gin – Vice President-Investor Relations and Communications
Vish Seshadri – Chief Executive Officer
Madhav Vasanthavada – Chief Commercial Officer and Head-Business Development
Brian Kevany – Chief Technical Officer
Joe Vazzano – Chief Financial Officer
Conference Call Participants
Rick Miller – Cantor Fitzgerald
Steven Willey – Stifel
Ram Selvaraju – H.C. Wainwright
James Molloy – Alliance Global Partners
David Bautz – Zacks Small Cap Research
Operator
Good day and welcome to the Abeona Therapeutics First Quarter 2025 Conference Call. At this time all participants are in a listen only mode and a question and answer session will follow the formal presentation. [Operator Instructions]. Please note this conference is being recorded.
I will now turn the conference over to your host Mr. Greg Gin. Sir, you may begin.
Greg Gin
Thank you Ali and good morning and thanks everyone for joining us on our first quarter 2025 results conference call. During this call we will refer to the press release issued this morning announcing the financial results. It’s available on our corporate website at www.abeonatherapeutics.com.
We anticipate making projections and forward looking statements during today’s call which are made pursuant to the safe harbor provisions of the federal securities laws. These forward looking statements are based on current expectations and are subject to change.
Actual results may differ materially from those expressed or implied in the forward looking statements due to various factors including but not limited to those outlined in our form 10K and periodic reports filed with the SEC. These documents are available on our website at www.abeonatherapeutics.com.
Joining me today on today’s call with prepared remarks are Dr. Vish Seshadri, Chief Executive Officer, Dr. Madhav Vasanthavada, Chief Commercial Officer and Joe Vazzano, Chief Financial Officer. Also, Dr. Brian Kevany, Chief Technical
Read the full article here